BPC-157 Research Overview: What Published Studies Have Examined
BPC-157 is one of the most searched research peptides, and also one of the most misrepresented. This overview summarizes what the published literature has actually examined — and, just as important, what it hasn't.
What BPC-157 is
BPC-157 ("Body Protection Compound") is a synthetic pentadecapeptide — fifteen amino acids, molecular weight ~1419 Da — whose sequence is derived from a partial segment of a protective protein identified in human gastric juice. Unusually for a peptide, it is stable in acidic environments, one reason it became a favored tool compound in gastrointestinal research. It is not an approved drug in any jurisdiction; all material sold as BPC-157 is research-grade chemical synthesis.
The main research threads
Soft-tissue and musculoskeletal models
The largest body of work comes from rodent studies of tendon, ligament and muscle injury. Across transection and crush models, investigators have reported accelerated fibroblast migration and outgrowth, improved collagen organization, and faster functional recovery in treated animals versus controls. In vitro work with tendon fibroblasts suggests involvement of the FAK–paxillin pathway in the migration effect.
Gastrointestinal protection
BPC-157's original research context. Rodent studies have examined protection of gastric and intestinal mucosa against NSAID-induced and alcohol-induced lesions, anastomosis healing, and models of inflammatory bowel injury. This remains the most extensively replicated area of the literature.
Angiogenesis and the nitric-oxide system
Several groups have reported increased VEGF expression and capillary formation in injury models, along with interactions with the NO pathway — effects that may underlie the healing observations above rather than being separate phenomena.
The honest limits of the evidence
- Species: the evidence base is overwhelmingly rodent. There are no published, peer-reviewed human clinical trials establishing efficacy for any indication.
- Lab concentration: a large share of publications comes from a small number of research groups; independent replication at scale is thinner than the citation count suggests.
- Regulatory status: BPC-157 is not approved for human use anywhere, and anti-doping bodies list it as a prohibited unapproved substance.
Practical notes for the laboratory
BPC-157 dissolves readily in bacteriostatic water and is notably stable for a peptide — but standard practice still applies: refrigerate after reconstitution, protect from light, and confirm identity and purity against the batch certificate of analysis.
We stock independently tested BPC-157 (10mg vials) and a BPC-157 + TB-500 combination vial used in comparative protocols — see our BPC-157 vs TB-500 comparison for how the two differ. For research use only — not for human or veterinary use.